Gritstone bio, Inc. Common Stock

Go to Gritstone bio, Inc. Common Stock Website

$0.03

(%)
Live
Previous Close

$0.0322

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Gritstone bio, Inc. is facing a class action lawsuit alleging that the company made false and misleading statements about the timeline and funding for its COVID-19 vaccine trial, leading to a workforce reduction and stock price decline.

Related tickers: GRTS.

Read Full Article

Gritstone bio, Inc. (NASDAQ: GRTS) is facing a securities class action lawsuit due to alleged false and/or misleading statements about its ability to launch a COVID-19 vaccine study and maintain its financial position. Investors who purchased Gritstone securities between March 9, 2023 and February 29, 2024 are encouraged to join the lawsuit by the August 6, 2024 deadline.

Related tickers: GRTS.

Read Full Article
Trending Tickers

Please sign in to view